|
NUP93 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.31659999999634E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.51250000000247E-05 |
| Normal-vs-Stage2 |
2.28310000000009E-05 |
| Normal-vs-Stage3 |
1.69083999999042E-05 |
| Normal-vs-Stage4 |
1.238750E-03 |
| Stage1-vs-Stage2 |
4.704200E-01 |
| Stage1-vs-Stage3 |
3.605000E-01 |
| Stage1-vs-Stage4 |
3.344400E-01 |
| Stage2-vs-Stage3 |
9.362600E-01 |
| Stage2-vs-Stage4 |
2.071000E-01 |
| Stage3-vs-Stage4 |
1.592020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.18489999999072E-05 |
| Normal-vs-AfricanAmerican |
3.155100E-04 |
| Normal-vs-Asian |
6.623100E-03 |
| Caucasian-vs-AfricanAmerican |
5.441800E-01 |
| Caucasian-vs-Asian |
6.619800E-01 |
| AfricanAmerican-vs-Asian |
8.455400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62193999999616E-05 |
| Normal-vs-Female |
1.614660E-04 |
| Male-vs-Female |
7.521600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.223600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.39949999999434E-05 |
| Normal-vs-Age(61-80Yrs) |
3.51790000000518E-05 |
| Normal-vs-Age(81-100Yrs) |
2.28989999999651E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.566100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.192360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.972500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.816400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.795200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.559400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.063770E-03 |
| Normal-vs-Grade 2 |
2.21589999999106E-05 |
| Normal-vs-Grade 3 |
1.84720999999444E-05 |
| Normal-vs-Grade 4 |
1.736580E-03 |
| Grade 1-vs-Grade 2 |
2.434600E-01 |
| Grade 1-vs-Grade 3 |
1.839180E-01 |
| Grade 1-vs-Grade 4 |
8.932200E-01 |
| Grade 2-vs-Grade 3 |
7.457400E-01 |
| Grade 2-vs-Grade 4 |
2.085200E-01 |
| Grade 3-vs-Grade 4 |
1.572380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.48850000003531E-06 |
| Normal-vs-ccB subtype |
5.006000E-04 |
| ccA subtype-vs-ccB subtype |
1.962830E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.83490000000131E-05 |
| Normal-vs-N1 |
3.899000E-01 |
| N0-vs-N1 |
1.482590E-01 |
|
|
